If you have burning, tingling, or numb feet, you have probably seen red light devices sold as a fix for nerve pain. Some ads point to studies that show real relief. Others point to studies that show nothing at all. Both sets of studies are real. So what is going on?

The short answer: “red light therapy for neuropathy” is not one single thing. The device, the color of the light, the strength, and the number of sessions all change the result. Once you sort the research by those details, the confusion mostly clears up. This post walks you through it as a shopper, not a salesperson.

A quick plain-English setup

Neuropathy means nerve damage. The most common cause is diabetes. High blood sugar over time harms the small nerves in the feet and hands. This is called diabetic peripheral neuropathy, or DPN. It can feel like burning, pins and needles, or numbness.

Red light therapy in this context has a science name: photobiomodulation, or PBM. It means using red or near-infrared light to nudge cells to work better. Near-infrared is light just past what your eye can see. The idea is that certain light wavelengths help cells make more energy and calm inflammation. Wavelength is measured in nanometers (nm), which is just a way to describe the exact color of the light.

Keep those two dials in mind as we go: the color of the light (nm) and the dose (how much energy reaches the tissue).

The part that creates the confusion

For years the most advertised neuropathy light devices used a technology called monochromatic infrared energy, or MIRE. The best known brand was Anodyne. These are near-infrared LED pads, often around 890 nm. The FDA cleared them back in 1994 to increase circulation and reduce pain.

Here is the catch. When researchers ran the toughest kind of test, a “sham-controlled” trial, MIRE did not do well. A sham is a fake treatment that looks and feels real but delivers no active light. It lets you see if the real device beats the placebo effect. In 4 of 5 of these strict trials, MIRE was no better than sham for foot sensation, balance, pain, or quality of life. One well-known sham-controlled study in the journal Diabetes Care found no meaningful difference between the real and fake treatment.

That is a big reason insurers still label this use “investigational” and usually will not pay for it. So if your only picture of red light for neuropathy comes from those older MIRE devices, skepticism is fair.

The newer research looks better

Now the hopeful part. Newer PBM trials, many using lasers at specific wavelengths and doses, are showing measurable gains.

A 2025 randomized trial followed 200 people with diabetic neuropathy. Half got real laser light on the tops and soles of their feet. Half got a sham. The light was a red helium-neon laser at 632.8 nm, given over 10 days. The treated group reported less pain and better protective sensation in the feet. The researchers also saw changes in two nerve-related markers in the blood, which hints the nerves themselves were responding. This was a single-blind study with short follow-up, so it is strong but not the final word.

Earlier work points the same way. One study reported about a 65 percent drop in pain scores after 10 sessions of 830 nm laser light. Another using 808 nm light reported better pain and quality of life. The methods vary, so the exact numbers do too. But the pattern is consistent.

So why the split? It is mostly the dose

A 2025 review in Lasers in Medical Science looked at this directly. The authors pulled together 23 studies from 2015 to 2025 and asked a simple question. What settings actually work?

The most consistent results showed up with these settings:

• Wavelength around 630 to 670 nm (red) or 808 to 904 nm (near-infrared)
• A dose of about 3 to 10 J/cm2 (a J/cm2, or joule per square centimeter, is just a measure of how much light energy lands on the skin)
• Output power of roughly 45 to 100 mW
• At least 12 sessions, not one or two

The review’s honest conclusion was two-sided. PBM looks like a promising, safe, and helpful add-on for diabetic neuropathy. But the field still has no agreed dosing standard, so results are uneven and more good trials are needed.

Read that list again and the disagreement makes sense. A device with the wrong wavelength, too little power, or used only a couple of times can easily land in the “no effect” group. A proper protocol, repeated enough times, is where the wins show up. The dose is doing a lot of the work.

A glimpse of the future: chemo nerve damage

Diabetes is not the only cause of neuropathy. Some cancer drugs damage nerves too. This is called chemotherapy-induced peripheral neuropathy.

A small 2022 pilot trial called NEUROLASER tested PBM during chemotherapy in 32 breast cancer patients. The people who got light kept a better quality of life. They also avoided the rise in nerve symptoms seen in the group that did not get light. It is early and small. But using light to protect nerves before damage sets in is an exciting direction to watch.

How to shop like a skeptic

If you want to try red light for neuropathy, here is a practical checklist drawn from the research.

• Ask the wavelength. Look for red in the 630 to 670 nm range, near-infrared in the 808 to 904 nm range, or a device that offers both.
• Ask the power and dose. Look for the output in milliwatts (mW) and the dose in J/cm2. If a seller cannot tell you, that is a red flag. Underpowered pads may do nothing.
• Plan for consistency. The positive trials used about 12 or more sessions. One weekend of use is not a fair test.
• Treat the actual problem area. Cover both the top and the sole of the foot.
• Keep it as an add-on. This is the most important point. Blood sugar control is still the foundation for diabetic neuropathy. Light does not replace it.

And a few safety notes. PBM is very safe, with a low risk of burns when used as directed. Never stop a prescribed medicine on your own. See your doctor for any new numbness, a foot wound that will not heal, or pain that is getting worse. In diabetes, foot problems need real medical eyes, not just a light.

The bottom line

The studies do not really disagree once you sort them by device and dose. The old, heavily marketed MIRE pads did not beat sham in the strictest tests. Newer laser-based PBM, used at the right wavelength and dose for enough sessions, is showing genuine relief. That is a hopeful trend for a condition with few easy answers. Just go in with clear eyes. Ask about wavelength, power, and dose, commit to a real course of sessions, and keep your medical care front and center. Used that way, red light is a reasonable tool to try, not a miracle and not a scam.